Women's HealthNCT00505609
Efficacy of the Standard Days Method of Family Planning
A study testing Standard Days Method in people with Women's Health, run by Georgetown University at 3 sites in 3 countries.
Trial summary
The Standard Days Method® is a fertility awareness-based method of family planning in which users avoid unprotected intercourse during cycle day 8 through 19. The method is most appropriate for women with cycles that usually range 26-32 days. Read more about this study
- Who is it for?
- Ages 18 to 39 years, women only
- Conditions the study is for
- Women's Health
- What is being tested?
- Standard Days Method
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 478 participants
- Where
- 3 sitesin 3 countries
- Study dates
- Nov 1999to Oct 2001
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 39 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Women
- Age 18-39
- Married or living with stable partner
- At least three cycles (four periods) since last birth
- Self reported cycles 26-32 days long
- Willing to avoid intercourse 12 consecutive days every cycle
Show all 12Show fewer
- Partners willing to collaborate
- No known infertility problems
- Not at risk for sexually transmitted infections
- No contraindications of pregnancy
- No use of hormonal contraceptives in three months prior to admission
- Desiring to avoid pregnancy for at least one year
Who cannot join
- Women who have cycles outside of the 26-32 day range
- Women/couples not interested in the method
- Women who have not yet had 3 regular cycles after childbirth
- Women who have used hormonal contraceptives in the previous 3 months
- Those women at risk for sexual transmitted infections
- Women/couples who cannot manage the fertile days by avoiding intercourse or using a barrier method
Trial locations and contacts
3 sites in 3 countries.
3 sites in 3 countries
Bolivia1 site
Institute for Reproductive Health, Bolivia
La Paz, Sopocachi, 243
Philippines1 site
Institute for Reproductive Health, Philippines
Quezon City, Loyola Heights, 1108
About this study
The Standard Days Method® is a fertility awareness-based method of family planning in which users avoid unprotected intercourse during cycle day 8 through 19. The method is most appropriate for women with cycles that usually range 26-32 days. The clinical trial tested the contraceptive efficacy of the Standard Days Method. A total of 478 women, age 18-39 years, in Bolivia, Peru, and the Philippines, with self-reported cycles of 26-32 days, desiring to delay pregnancy at least one year were admitted to the study and followed for up to 13 cycles of method use.
Read the detailed description
The Standard Days Method® is a fertility awareness-based method of family planning. Users avoid unprotected intercourse during cycle day 8 through cycle day 19. The method is most effective for women with cycles that usually range 26-32 days. It was developed by applying various formulae (i.e. various numbers of days and various sets of days) to over 7500 menstrual cycles in an existing data set from the World Health Organization, to determine which formula would provide the optimal balance between he length of the identified fertile period and the efficacy in avoiding unplanned pregnancy.
The purpose of the clinical trial was to test the efficacy of the method in preventing pregnancy.
Participants were from five sites in Bolivia, Peru, and the Philippines. In all sites, the Institute for Reproductive Health trained 5-10 health workers (service providers) in teaching the Standard Days Method to study subjects and in study procedures. Method provision involved a counseling session in which the woman (or the couple, if her partner was available) was instructed in the use of the method, and counseled on the importance of following the method recommendations to avoid pregnancy.
To assist women in monitoring their cycles, the provider gave them CycleBeads® a mnemonic device, a string of 32 beads in which each beads represents a day of the menstrual cycle. The first bead is red, representing the first day of menses; the next 6 beads are brown, representing the additional non-fertile days preceding the fertile window; the next 12 beads are white, representing days that should be considered fertile (8-19); and the remaining 13 beads are brown, again representing non-fertile days. It also has a moveable, tight-fitting rubber ring that is used to mark the current day of the cycle. Women were instructed to place the ring on the red bead on the day their menses began, and move the ring one bead per day until their menses returned. They also were told that to avoid pregnancy they should not have unprotected intercourse on the days the ring was on a white bead. If they had menstrual bleeding before day 27 of the cycle (i.e., a cycle shorter than 26 days), or if their menses had not occurred by the day after they completed all 32 beads (i.e., a cycle longer than 32 days), they were instructed to contact their provider for further assessment and advice. Women who had two cycles outside the 26 through 32 day range during the study period were advised to use another method, and were withdrawn from the study.
A total of 478 women wishing to use the Standard Days Method and meeting the eligibility criteria were admitted to the study after signing an informed consent form and interviewed monthly until they either completed 13 cycles of method use or left the study for other reasons. The first level of data collection was administered by the clients themselves. Each woman was asked to keep a daily diary to record menstrual bleeding, intercourse, and use of any other contraceptive method. The information on the diary card was reviewed by the clients and the service provider during each of the monthly follow-up contacts. In addition, follow-up forms were administered, which included questions concerning method use, satisfaction, and willingness to continue in the study.
Women who had not had their menses by day 42 of their cycle were tested for pregnancy. If results were negative, they were followed until they tested positive or their menses returned. Loss to follow-up was minimized by interviewing study participants in their homes and actively seeking out each participant, with a minimum of three attempts per cycle.
Single-decrement multi-censoring life tables were used to calculate pregnancy rates.
- Conditions
- Women's Health
- Being tested
- Standard Days Method
- Keywords
- fertility awareness-based method, family planning, Standard Days Method, Institute for Reproductive Health, Efficacy, CycleBeads
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard Days MethodBehavioural
Also called CycleBeads
The Standard Days Method is a fertility awareness-based method of family planning. Users avoid unprotected intercourse during cycle days 8 to 19. Study participants were for up to 13 cycles of method use.
| Study group | Role | What they receive |
|---|---|---|
| A | Experimental | The Institute for Reproductive Health trained health providers in teaching the Standard Days Method to study subjects and in study procedures. Providers counseled study participants in method use. Participants were followed for up to 13 cycles of method use. Receives: Behavioral: Standard Days Method |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pregnancy rate with correct method use
Measured: 1 year (13 cycles)
Secondary outcomes (1)
Pregnancy rate with typical method use
Measured: 1 year (13 cycles)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2007 (estimated)
- Study startNov 1999
- Study completionOct 2001
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Women's HealthStudies of the same condition, open and under way.
- More trials run by Georgetown UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 478 participants (actual)
Sponsor and investigators
- Lead sponsor
- Georgetown University
- Sponsor type
- University, hospital or other
- Collaborators
- United States Agency for International Development (USAID)
- Investigators
- Victoria H. Jennings, PhD, Principal investigator, Georgetown University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00505609
- Sponsor's protocol ID
- SDM-IRH
- Status last verified
- Jul 2007
- First submitted
- 20 Jul 2007
- Last updated
- 23 Jul 2007
- Results posted
- No
- Data monitoring committee
- No
Publications
Arevalo M, Jennings V, Sinai I. Efficacy of a new method of family planning: the Standard Days Method. Contraception. 2002 May;65(5):333-8. doi: 10.1016/s0010-7824(02)00288-3.
PubMed 12057784
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of the Standard Days Method of Family Planning
- ClinicalTrials.gov ID
- NCT00505609
- Acronym / sponsor ID
- SDM-IRH
- Conditions
- Women's Health
- Keywords
- fertility awareness-based method, family planning, Standard Days Method, Institute for Reproductive Health, Efficacy, CycleBeads
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 478 participants (actual)
- Lead sponsor
- Georgetown UniversityUniversity, hospital or other
- Collaborators
- United States Agency for International Development (USAID)
- Study start
- Nov 1999
- Study completion
- Oct 2001 (actual)
- First posted
- 23 Jul 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Standard Days Method® is a fertility awareness-based method of family planning in which users avoid unprotected intercourse during cycle day 8 through 19. The method is most appropriate for women with cycles that usually range 26-32 days. The clinical trial tested the contraceptive efficacy of the Standard Days Method. A total of 478 women, age 18-39 years, in Bolivia, Peru, and the Philippines, with self-reported cycles of 26-32 days, desiring to delay pregnancy at least one year were admitted to the study and followed for up to 13 cycles of method use.
Detailed description
The Standard Days Method® is a fertility awareness-based method of family planning. Users avoid unprotected intercourse during cycle day 8 through cycle day 19. The method is most effective for women with cycles that usually range 26-32 days. It was developed by applying various formulae (i.e. various numbers of days and various sets of days) to over 7500 menstrual cycles in an existing data set from the World Health Organization, to determine which formula would provide the optimal balance between he length of the identified fertile period and the efficacy in avoiding unplanned pregnancy.
The purpose of the clinical trial was to test the efficacy of the method in preventing pregnancy.
Participants were from five sites in Bolivia, Peru, and the Philippines. In all sites, the Institute for Reproductive Health trained 5-10 health workers (service providers) in teaching the Standard Days Method to study subjects and in study procedures. Method provision involved a counseling session in which the woman (or the couple, if her partner was available) was instructed in the use of the method, and counseled on the importance of following the method recommendations to avoid pregnancy.
To assist women in monitoring their cycles, the provider gave them CycleBeads® a mnemonic device, a string of 32 beads in which each beads represents a day of the menstrual cycle. The first bead is red, representing the first day of menses; the next 6 beads are brown, representing the additional non-fertile days preceding the fertile window; the next 12 beads are white, representing days that should be considered fertile (8-19); and the remaining 13 beads are brown, again representing non-fertile days. It also has a moveable, tight-fitting rubber ring that is used to mark the current day of the cycle. Women were instructed to place the ring on the red bead on the day their menses began, and move the ring one bead per day until their menses returned. They also were told that to avoid pregnancy they should not have unprotected intercourse on the days the ring was on a white bead. If they had menstrual bleeding before day 27 of the cycle (i.e., a cycle shorter than 26 days), or if their menses had not occurred by the day after they completed all 32 beads (i.e., a cycle longer than 32 days), they were instructed to contact their provider for further assessment and advice. Women who had two cycles outside the 26 through 32 day range during the study period were advised to use another method, and were withdrawn from the study.
A total of 478 women wishing to use the Standard Days Method and meeting the eligibility criteria were admitted to the study after signing an informed consent form and interviewed monthly until they either completed 13 cycles of method use or left the study for other reasons. The first level of data collection was administered by the clients themselves. Each woman was asked to keep a daily diary to record menstrual bleeding, intercourse, and use of any other contraceptive method. The information on the diary card was reviewed by the clients and the service provider during each of the monthly follow-up contacts. In addition, follow-up forms were administered, which included questions concerning method use, satisfaction, and willingness to continue in the study.
Women who had not had their menses by day 42 of their cycle were tested for pregnancy. If results were negative, they were followed until they tested positive or their menses returned. Loss to follow-up was minimized by interviewing study participants in their homes and actively seeking out each participant, with a minimum of three attempts per cycle.
Single-decrement multi-censoring life tables were used to calculate pregnancy rates.
Study design
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| A | Experimental | Behavioral: Standard Days MethodThe Institute for Reproductive Health trained health providers in teaching the Standard Days Method to study subjects and in study procedures. Providers counseled study participants in method use. Participants were followed for up to 13 cycles of method use. |
Who may qualify
- Ages
- 18 to 39 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (12 listed)
- Women
- Age 18-39
- Married or living with stable partner
- At least three cycles (four periods) since last birth
- Self reported cycles 26-32 days long
Key exclusion criteria (6 listed)
- Women who have cycles outside of the 26-32 day range
- Women/couples not interested in the method
- Women who have not yet had 3 regular cycles after childbirth
- Women who have used hormonal contraceptives in the previous 3 months
- Those women at risk for sexual transmitted infections
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard Days MethodAlso: CycleBeadsThe Standard Days Method is a fertility awareness-based method of family planning. Users avoid unprotected intercourse during cycle days 8 to 19. Study participants were for up to 13 cycles of method use. | Behavioural | A |
Primary outcome
Pregnancy rate with correct method use
Time frame: 1 year (13 cycles)
1 secondary outcome
Pregnancy rate with typical method use
Time frame: 1 year (13 cycles)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2007.
- Results publication: PubMed 12057784Arevalo M, Jennings V, Sinai I. Efficacy of a new method of family planning: the Standard Days Method. Contraception. 2002 May;65(5):333-8. doi: 10.1016/s0010-7824(02)00288-3.
Related trials for Women's Health
Not yet recruiting
Radiofrequency and Pelvic Floor Exercise for Primary Dysmenorrhea
Primary Dysmenorrhea
RecruitingObservational study
Lived Experiences of Women Diagnosed With HPV Infection
Human Papillomavirus Infection
Recruiting
Restoring Emotional Needs With Exogenous Ketones for Women With Postpartum Depression
Postpartum Depression (PPD)
RecruitingPhase 2/3
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Menopause, Menopause Hot Flashes
Recruiting
Dance-Based Exercise Versus Clinical Pilates in Women With Overweight or Obesity
Overweight, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Victoria H. Jennings, PhD principal investigator
Georgetown University
3 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard Days Method in people with Women's Health, run by Georgetown University at 3 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jul 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Bolivia, Peru, Philippines. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pregnancy rate with correct method use (time frame: 1 year (13 cycles)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00505609, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2007.